LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination.
Garibashvili T, Heckmann JG (2022)
Publication Type: Journal article, Letter
Publication year: 2022
Journal
Book Volume: 4
Journal Issue: 1
DOI: 10.1186/s42466-022-00187-8
Abstract
A 71-year-old male patient was diagnosed with LGI1 encephalopathy 4 weeks following a first ChAdOx1 nCov-19 vaccination. Extensive work-up including analysis of CSF and PET examination did not reveal a tangible cause so that a vaccine-associated encephalopathy was considered as differential diagnosis. Under steroid treatment, the faciobrachial dystonic seizures subsided.
Involved external institutions
Germany (DE)How to cite
APA:
Garibashvili, T., & Heckmann, J.G. (2022). LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 4(1). https://dx.doi.org/10.1186/s42466-022-00187-8
MLA:
Garibashvili, Tamara, and Josef Georg Heckmann. "LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination." Neurological Research and Practice 4.1 (2022).
BibTeX: Download